Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0117573
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Activin a Induction of Erythroid Differentiation Sensitizes K562 Chronic Myeloid Leukemia Cells to a Subtoxic Concentration of Imatinib

American Journal of Physiology - Cell Physiology
PhysiologyCell Biology
2014English

Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Spautin-1, a Novel Autophagy Inhibitor, Enhances Imatinib-Induced Apoptosis in Chronic Myeloid Leukemia

International Journal of Oncology
Cancer ResearchOncology
2014English

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?

ISRN Oncology
2014English

Global Proteome Quantification for Discovering Imatinib-Induced Perturbation of Multiple Biological Pathways in K562 Human Chronic Myeloid Leukemia Cells

Journal of Proteome Research
BiochemistryChemistry
2010English

ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells

Oncology Reports
MedicineCancer ResearchOncology
2017English

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

2012English

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

Gene Expression Signature of Primary Imatinib-Resistant Chronic Myeloid Leukemia Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy